Alzheimer's
GAP Statement on Recent Bio-Hermes-001 Publication in Alzheimer’s & Dementia
“We’re pleased and proud to report our latest paper using Bio-Hermes-001 data has been published in Alzheimer’s & Dementia. Many thanks to the co-authors who helped to bring this research article to light including Richard Mohs, Douglas Beauregard, Lynne Hughes, Cyndy Cordell, Allan Levey, M.D., Ph.D., Saima Rathore, Nicholas Seyfried, Erik Johnson, Jessie Nicodemus-Johnson, Joshua Christensen, and Robin […]
Neurology Advisor: CTAD 2025: Highlights in Alzheimer Disease Research
Tori Rodriguez, MA, LPC, AHC Publish DateJanuary 27, 202 At the 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, held December 1 to 4, 2025, in San Diego, California, researchers presented new data spanning observational studies, biomarker analyses, and clinical development programs in Alzheimer disease (AD). Key topics included emerging evidence on metabolic therapies such as […]
Las Vegas Sun: Alzheimer’s disease study brings new testing to Las Vegas
Alzheimer’s disease study brings new testing to Las Vegas Courtesy Axiom Brain Health’s Kaden Appleberry processes lab sample for study. By Katie Ann McCarver (contact) Monday, January 26, 2026 – 2 a.m. A Las Vegas stronghold in neurology is contributing to a new study spanning multiple states and countries related to the detection and diagnosis of Alzheimer’s disease. Clinical Neurology […]
Las Vegas site joins global study on Alzheimer’s blood test
by News 3 Staff,Updated Fri, January 23, 2026 at 1:20 PM LAS VEGAS (KSNV) — Clinical Neurology Specialists (CNS) in Las Vegas is participating in a groundbreaking international study sponsored by the Global Alzheimer’s Platform Foundation. The Bio-Hermes-002 study seeks volunteers with memory concerns to help identify blood or digital tests that could predict the presence of amyloid […]
GenomeWeb: LifeArc Joins Study to Evaluate Alzheimer’s Disease Finger-Prick Blood Test
Jan 20, 2026 | staff reporterSave for later NEW YORK — UK nonprofit research organization LifeArc said on Monday that it has partnered with the Global Alzheimer’s Platform Foundation (GAP) to evaluate a blood-based test for Alzheimer’s disease. The test is designed to detect three proteins — phosphorylated tau 217, glial fibrillary acidic protein, and neurofilament light […]
Global Alzheimer’s Platform Foundation Applauds Congressional Funding Increase for Alzheimer’s Research
Washington D.C., Jan 20, 2026, The Global Alzheimer’s Platform Foundation® (GAP) applauds the House and Senate Committees on appropriations releasing their final bipartisan FY2026 Labor–Health and Human Services–Education appropriations bill which increases funding for Alzheimer’s disease and other dementia research. “Congress’s bipartisan approval of increased funding for neurodegenerative research sends a powerful message to the millions of […]
The Independent: The finger prick blood test that could revolutionise Alzheimer’s diagnosis
The test aims to pick up three proteins known to be associated with Alzheimer’s Jane KirbyMonday 19 January 2026 11:14 GMT Bookmark popover Removed from bookmarksClose popover A pioneering trial has begun to assess whether a simple finger-prick blood test could offer an early diagnosis for Alzheimer’s disease, even before symptoms manifest. Experts are optimistic […]
LifeArc: Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin
A major international research project is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer’s disease. The trial is looking at three proteins in the blood that are associated with Alzheimer’s and comparing this with the current gold standard approach to diagnosing the disease that uses expensive brain […]
Providence Business News: Providence research company seeking participants for Alzheimer’s study
By Jacquelyn Voghel 01/18/2026 EAST PROVIDENCE – A national research institution’s Rhode Island location is calling for volunteers with Alzheimer’s disease to participate in a study attempting to identify predictive markers of the brain condition. K2 Medical Research – East Providence has begun enrolling participants in the Bio-Hermes 002 Study, an initiative of the Global Alzheimer’s Platform Foundation. The study seeks […]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Spear Bio for the Transformative Bio-Hermes-002 Study
Spear Bio joins collaborative study focused on new biomarkers designed to improvediagnosis of Alzheimer’s disease and dementias Washington D.C., Jan 12, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study. This collaboration will enhance this unique, observational platform […]